Results 101 to 110 of about 238,108 (114)
Some of the next articles are maybe not open access.
Preclinical and Clinical Pharmacology of DOV 216,303, a “Triple” Reuptake Inhibitor
CNS Neuroscience & Therapeutics, 2006Pal Czobor, Piotr Popik
exaly
3D plausible orbital stability close to asteroid (216) Kleopatra
Monthly Notices of the Royal Astronomical Society, 2015Othon Winter, Winter O C
exaly
DOV 216,303, a “Triple” Reuptake Inhibitor: Safety, Tolerability, and Pharmacokinetic Profile
Journal of Clinical Pharmacology, 2004Pal Czobor
exaly
The novel 5‐HT1A receptor antagonist, SDZ 216–525, decreases 5‐HT release in rat hippocampus in vivo
British Journal of Pharmacology, 1993Daniel Höyer, John R Fozard
exaly
SDZ 216–525, a selective and potent 5-HT1A receptor antagonist
European Journal of Pharmacology, 1993Daniel Höyer +2 more
exaly

